Sardona Therapeutics

📍 San Francisco, United States🗓 Founded 2021👥 16 employees💰 Last funded Jun 2021
Biotechnology Research🌐 sardonatx.com
Website LinkedIn
Sardona Therapeutics is a preclinical biotechnology company building the leading platform to develop small molecule drugs that target RNA-binding proteins and provide patients with therapy-resistant cancers novel, and potentially best-in-class, treatment options.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sardona Therapeutics?
Sardona Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sardona Therapeutics last raise funding?
The most recent investment in Sardona Therapeutics recorded on gritt.io was in June 2021.
When was Sardona Therapeutics founded?
Sardona Therapeutics was founded in 2021.
What industry is Sardona Therapeutics in?
Sardona Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sardona Therapeutics based?
Sardona Therapeutics is headquartered in San Francisco, United States.